AMELGEN 400 mg, vaginal pessary 15 pessaries
Active ingredients: Progesterone
Commercialized according to BDPMDispensing in France: Prescription only
Vaginal pessary15 pessariesvaginale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMELGEN 400 mg, ovule
- Pharmaceutical form
- ovule
- Route of administration
- vaginale
- Presentation description
- film(s) thermosoudé(s) PVC polyéthylène de 15 ovule(s)
- Marketing authorisation holder
- GEDEON RICHTER ( HONGRIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Jul 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60880975CIP73015689CIP133400930156896Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROGESTÉRONEovule | 400 mg · un ovule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.